Vildagliptin

• Description :

  Vildagliptin, previously identified as LAF237, is a new oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  303.4

• Molecular Formula :

  C17H25N3O2

• Notes :

  Research use only, not for human use.

• Receptor :

  DPP-4

• CAS Number :

  274901-16-5